Petros Pharmaceuticals: Men’s health pharmaceutical company Petros Pharmaceuticals (NASDAQ:PTPI) tops the Fintel leaderboard for the week. The stock has 25.4% of its float short with short interest up 459% in recent weeks, according to Fintel. Short interest is up 2,470% in the last month on shares of PTPI. Fintel shows a cost to borrow of 254%, which is one of the highest on record.$Petros Pharmaceuticals Inc(PTPI)$
精彩评论